Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve allegations of violating the False Claims Act and Anti-Kickback Statute ...
Co-pay accumulators and maximizers are 2 programs that insurers have started implementing to help them redirect financial assistance from the patient, said Kimberly Westrich, MA, chief strategy ...
Copay maximizers allow plans to “maximize” the value extracted from copay assistance programs by adjusting a patient’s cost-sharing to the maximum amount of available assistance and not allowing the ...
As someone living with a rare disease in Ohio, I know how fragile access to life-saving treatment can be. A bill to help patients with rare or life-threatening illnesses is currently being debated in ...
CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology and pharmaceutical company spanning multiple sectors, today announced the ...
A funding shortfall for a key copay assistance program to help make eye injections more affordable for low-income patients has caused widespread disruption in treatment, researchers have found. The ...
Johnson & Johnson has sued divisions of health insurer Cigna, accusing them of working with a drug-benefit middleman to drain J&J financial-assistance funds earmarked for patients taking some of its ...
The 2025 results demonstrate Paysign’s expanding presence across the healthcare ecosystem. Substantial growth in patient and client savings highlights the advanced efficacy of the company’s solutions ...
When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback